Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
Condition(s):Posterior Capsule Opacification; Ocular HypertensionLast Updated:July 16, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Posterior Capsule Opacification; Ocular HypertensionLast Updated:July 16, 2019Completed
Condition(s):Glaucoma and Ocular HypertensionLast Updated:December 25, 2012Completed
Condition(s):Ocular RednessLast Updated:July 31, 2014Completed
Condition(s):RosaceaLast Updated:October 10, 2018Completed
Condition(s):Eye Diseases; Injection Complication; Intraocular PressureLast Updated:August 24, 2020Completed
Condition(s):Rosacea; ErythemaLast Updated:August 25, 2021Completed
Condition(s):HyperemiaLast Updated:October 23, 2019Completed
Condition(s):HyperemiaLast Updated:October 23, 2019Completed
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:February 15, 2022Completed
Condition(s):Post-Injection Intraocular Pressure SpikesLast Updated:May 1, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.